focus -WSS

focus

author：hotspot 2025-09-27 23:20:06 - browse：61424

Christoph Lengauer stands for a portrait. -- biotech coverage from STAT — Christoph Lengauer, co-founder and CSO of Curie.Bio Vanessa Leroy for STAT

Curie.Bio, the new biotech investment firm and incubator launched earlier this year by a group of industry veterans including Alexis Borisy and Zach Weinberg, has graduated its first startup.

The startup, Forward Therapeutics, is coming out of the incubator with three drug candidates for chronic inflammatory disorders. It also just closed its first major financing round: a $50 million Series A round led by BVF Partners, with participation from RA Capital Management and OrbiMed. That money should be enough for Forward to begin clinical trials — a rare feat in the biotech world, where companies often need to raise multiple private financing rounds in order to be ready for human tests.

“Usually, with Series A money, you get a development candidate, and use Series B to take molecules to the clinic,” Forward CEO Toufike Kanouni told STAT. But with the Curie team’s help, and the $8 million in seed financing it provided, Forward was able to move much faster.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： A revolution in caring for preterm infants

hotspot

WSS

Female surgeons have lower rates of long

There’s no way to know how good AI health technologies are

How dance can help health care workers heal from trauma

How should state employee insurance handle Wegovy?

Female surgeons have lower rates of long

India sets sights on home

focus

focus

knowledge

DIEP, the 'gold standard' of breast reconstruction, is under threat

Man who had jail sentence commuted by Trump arrested again

Wildfire smoke exposes gaps in outdoor worker protections

There’s no way to know how good AI health technologies are

23andMe had bad news about my health. I wish a person had delivered it

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Tori Bowie and the unacceptable rates of Black maternal death

How should state employee insurance handle Wegovy?

Hepatitis C has a cure — but many Americans still lack access to it

STAT Readout Newsletter: Today in biotech, life science news

knowledge

A fraught question for the kids of Alzheimer’s: Is it coming for us?

Why the Crimean Bridge is key to Russia's war in Ukraine

New warning issued for rebooking air travel after delays, cancellations

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

leisure time

hotspot

leisure time

knowledge